CT Cardiomegaly vs uMI Panvivo

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CT Cardiomegaly

by Innolitics

uMI Panvivo

by Shanghai United Imaging Healthcare Co., Ltd.

AI Verdict

Tool A is a specialized command-line software designed for automated cardiothoracic ratio measurement from existing CT chest images. In contrast, Tool B is a comprehensive AI-powered PET/CT imaging system that generates high-resolution diagnostic images for oncology, cardiology, and neurology. While both leverage AI in radiology and cardiology, Tool A offers a specific analytical function for CT data, whereas Tool B provides an entire imaging modality with integrated AI workflows.

Choose CT Cardiomegaly if…

Choose CT Cardiomegaly if your primary need is an automated, quantitative analysis of existing CT chest images to detect cardiomegaly. This command-line software is ideal for integrating into existing radiology workflows to quickly generate precise cardiothoracic ratio measurements and reports, providing objective data for physician review.

View CT Cardiomegaly →

Choose uMI Panvivo if…

Choose uMI Panvivo if your facility requires a comprehensive, high-resolution PET/CT imaging system for advanced diagnostics across oncology, cardiology, and neurology. This integrated solution offers superior image quality and intelligent workflows, making it suitable for acquiring new, detailed diagnostic images and enhancing overall departmental imaging capabilities.

View uMI Panvivo →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CT Cardiomegaly	uMI Panvivo
Pricing	Contact for pricing	Contact for pricing
Deployment	Docker Container (Ubuntu 20.04), command-line software	On-premise (scalable modality, departmental, or enterprise solution; compact design allows installation in smaller spaces without a dedicated equipment room).
BAA Available	Unknown	Yes AI-estimated
FDA Status	Yes AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

uMI Panvivo

Tool B, uMI Panvivo, is an integrated PET/CT system with 'intelligent workflows' and features like ambient lighting and a breathing guide, suggesting a user-friendly experience for both patients and clinical staff operating the system. In contrast, Tool A, CT Cardiomegaly, is described as 'command-line software' deployed in a Docker container, indicating a more technical interface primarily for IT or research users rather than direct clinical interaction.

Clinical Value

uMI Panvivo

Tool B, uMI Panvivo, offers 'advanced diagnostic precision with high-resolution imaging and intelligent workflows for oncology, cardiology, and neurology,' covering a broad range of critical clinical applications. While Tool A, CT Cardiomegaly, provides valuable quantitative data for cardiomegaly detection, its clinical scope is more specialized compared to Tool B's comprehensive diagnostic capabilities across multiple specialties.

Pricing & Value

uMI Panvivo

Tool B, uMI Panvivo, provides more transparent value propositions, including 'Tiered service agreements,' 'Lifetime software and functionality upgrades included with active service agreement,' and 'All-in configurations with every available application included upfront.' Tool A, CT Cardiomegaly, only states 'contact for pricing' without any additional details on included services or upgrade policies, offering less clarity on long-term value.

Enterprise Readiness

uMI Panvivo

Both tools are FDA-cleared, HIPAA compliant, and offer BAAs, indicating foundational enterprise readiness. However, Tool B, uMI Panvivo, explicitly states its deployment as an 'On-premise (scalable modality, departmental, or enterprise solution)' with a 'compact design allows installation in smaller spaces,' demonstrating a more comprehensive consideration for physical and organizational enterprise integration for a full imaging system. Tool A's Docker deployment is also enterprise-friendly for software, but Tool B's offering is more holistic for a complete medical device.

Innovation

uMI Panvivo

Tool B, uMI Panvivo, showcases innovation through its integration of 'AI-powered workflow' with cutting-edge hardware, including 'High NEMA spatial resolution (2.9mm)' and 'Exceptional TOF timing resolution (219 ps),' representing a holistic advancement in diagnostic imaging technology. Tool A, CT Cardiomegaly, is innovative in automating a specific measurement using machine learning, but Tool B's combination of advanced hardware and AI across multiple applications suggests a broader technological leap.

Support & Docs

uMI Panvivo

Tool B, uMI Panvivo, explicitly mentions 'Lifetime software and functionality upgrades included with active service agreement,' which directly implies ongoing support and access to updated documentation. Tool A, CT Cardiomegaly, provides no specific information regarding support, documentation, or upgrade policies in the provided facts, making Tool B the clear winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CT Cardiomegaly	uMI Panvivo
Product Name	CT Cardiomegaly	uMI Panvivo
Company	Innolitics	Shanghai United Imaging Healthcare Co., Ltd.
Primary Function	Automated cardiothoracic ratio measurement from CT chest images, assisting physicians in cardiomegaly detection with quantitative data.	AI-powered PET/CT system offering advanced diagnostic precision with high-resolution imaging and intelligent workflows.
Target Categories	Cardiology AI, Radiology & Imaging AI	Cardiology AI, Oncology AI, Radiology & Imaging AI
Target Specialties	Cardiology, Radiology	Nuclear Medicine, Oncology, Radiology

Videos

Demos, reviews, and walkthroughs featuring CT Cardiomegaly and uMI Panvivo.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows, considering one is a standalone image analysis software and the other is an entire imaging system?

Tool A (CT Cardiomegaly) is a command-line software that processes existing CT images to provide quantitative cardiothoracic ratio measurements, fitting into a post-acquisition analysis workflow. Tool B (uMI Panvivo) is an integrated PET/CT imaging system with AI-powered workflows for image acquisition and reconstruction across multiple specialties like oncology, cardiology, and neurology.

What specific metrics or validation studies are available to demonstrate the accuracy and sensitivity of the AI algorithms in each tool for their respective clinical applications?

Tool A has been validated against manual measurements by board-certified radiologists, showing a mean difference for CTR of 0.0012 and for Heart to Chest Area Ratio of 0.0036, both meeting targets. Tool B, as a PET/CT system, boasts high NEMA spatial resolution of 2.9mm and TOF timing resolution of 219 ps for image quality, with AI-powered workflows like OncoFocus designed to reduce respiratory motion artifacts for accurate quantification.

Given Tool A's focus on cardiomegaly detection and Tool B's broader scope across oncology, cardiology, and neurology, how do their clinical applications differ in terms of depth versus breadth?

Tool A offers a specialized, quantitative analysis for cardiomegaly detection from CT chest images, providing focused data to assist in evaluating cardiac size. Tool B, as a comprehensive PET/CT system, provides broad diagnostic capabilities across oncology, cardiology, and neurology, integrating AI into the entire imaging and reconstruction process for multiple disease states.

Beyond basic reporting, what are the capabilities for integrating the output of these tools directly into a physician's EHR system for streamlined data access and decision-making?

Tool A generates PDF and JSON reports, which can be integrated into an EHR, though specific automation for direct EHR population would depend on the facility's IT infrastructure. Tool B, as an imaging system, would typically integrate via DICOM, and its AI-powered workflows would likely produce structured data that could be pushed to an EHR, but the depth of integration beyond image archiving would require further inquiry.

What is the expected learning curve for physicians and technologists to effectively utilize each tool, considering Tool A is command-line software and Tool B is an integrated imaging system with intelligent workflows?

Tool A, being command-line software, may require a steeper learning curve for users unfamiliar with such interfaces, primarily for IT staff or radiologists comfortable with scripting. Tool B, as an integrated PET/CT system, emphasizes intelligent workflows and user-friendly features like a breathing guide and collision-avoidance design, suggesting a more intuitive experience for technologists and physicians interacting with the imaging process itself.

What are the key considerations for deploying each tool across multiple clinical sites, particularly regarding infrastructure requirements and scalability?

Tool A, being a Docker containerized command-line software, offers high portability and can be scaled across multiple sites by deploying the container on existing IT infrastructure. Tool B, as an on-premise PET/CT system, requires physical installation and dedicated space at each site, though its compact design and scalable platform aim to facilitate multi-site deployment.

What audit-trail features are available in each tool to track the AI's decision-making process, data inputs, and any user interactions for clinical review and accountability?

Tool A generates PDF and JSON reports of its measurements, which serve as a record of the output, but explicit details on audit trails for the AI's internal processing or user modifications are not provided. For Tool B, while it features AI-powered workflows, information on the granularity of audit trails for AI decisions, data inputs, or user interactions within the system would need to be clarified by the vendor.